Literature DB >> 25786895

Clinical, histopathological, dermatoscopic and digital microscopic features of dermatofibroma: a retrospective analysis of 200 lesions.

E Şenel1, Y Yuyucu Karabulut2, S Doğruer Şenel3.   

Abstract

BACKGROUND: Dermatology literature lacks a study investigating both histopathological and dermatoscopic features of dermatofibroma.
OBJECTIVE: To analyse histopathological, dermatoscopic and digital microscopic features of dermatofibromas.
METHODS: Two hundred dermatofibromas and 190 patients were included and retrospectively evaluated. Nine histopathological and ten dermatoscopic patterns were used to classify the lesions. We identified four different types of dermatofibroma in digital microscopy.
RESULTS: The mean age of the patients was 42.18 ± 13.72 years. Dermatofibroma was more common in females (67%) and the male to female ratio was 1:1.97. The most common location was leg (41%). The most frequent histopathological variant was fibrocollagenous type (49%). Grenz zone was the most common histopathological finding (89%). The most frequent digital microscopic type was type 1 (63%).
CONCLUSIONS: We found that palisading variant displayed only pattern 6 in dermatoscopy and cellular variant showed type 3 significantly in digital microscopy.
© 2015 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2015        PMID: 25786895     DOI: 10.1111/jdv.13092

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  2 in total

1.  PDGFB Rearrangements in Dermatofibrosarcoma Protuberans of the Vulva: A Study of 11 Cases Including Myxoid and Fibrosarcomatous Variants.

Authors:  Khadijeh Jahanseir; Deyin Xing; Patricia T Greipp; William R Sukov; Gary L Keeney; Brooke E Howitt; J Kenneth Schoolmeester
Journal:  Int J Gynecol Pathol       Date:  2018-11       Impact factor: 2.762

2.  High-frequency ultrasound in the diagnosis of selected non-melanoma skin nodular lesions.

Authors:  Paweł Piłat; Adam Borzęcki; Mieczysław Jazienicki; Agnieszka Gerkowicz; Dorota Krasowska
Journal:  Postepy Dermatol Alergol       Date:  2019-11-12       Impact factor: 1.837

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.